<bill session="116" type="s" number="3862" updated="2020-09-24T04:24:02Z">
  <state datetime="2020-06-02">REFERRED</state>
  <status>
    <introduced datetime="2020-06-02"/>
  </status>
  <introduced datetime="2020-06-02"/>
  <titles>
    <title type="short" as="introduced">CEASE Act</title>
    <title type="short" as="introduced">CEASE Act</title>
    <title type="short" as="introduced">Combating Egregious Advertising through Sentencing Enhancement Act</title>
    <title type="short" as="introduced">Combating Egregious Advertising through Sentencing Enhancement Act</title>
    <title type="display">CEASE Act</title>
    <title type="official" as="introduced">A bill to increase the penalties applicable under the Federal Trade Commission Act during the COVID-19 emergency, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="G000562"/>
  <cosponsors>
    <cosponsor bioguide_id="C001047" joined="2020-06-02"/>
    <cosponsor bioguide_id="S001191" joined="2020-06-02"/>
  </cosponsors>
  <actions>
    <action datetime="2020-06-02">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2020-06-02" state="REFERRED">
      <text>Read twice and referred to the Committee on Commerce, Science, and Transportation.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSCM" name="Senate Commerce, Science, and Transportation" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Commerce"/>
    <term name="Cardiovascular and respiratory health"/>
    <term name="Civil actions and liability"/>
    <term name="Consumer affairs"/>
    <term name="Cosmetics and personal care"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="Fraud offenses and financial crimes"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Marketing and advertising"/>
  </subjects>
  <amendments/>
  <summary date="2020-06-02T04:00:00Z" status="Introduced in Senate">Combating Egregious Advertising through Sentencing Enhancement Act or the CEASE Act This bill prohibits and, increases the penalties for, certain commercial practices during the COVID-19 (i.e., coronavirus disease 2019) public health emergency.

Specifically, during such time period, it increases the criminal penalties for false advertising (1) for a first offense from not more than six months in prison and a $5,000 fine to not more than one year in prison and a $50,000 fine and (2) for subsequent offenses from not more than one year in prison and a $10,000 fine to not less than one year or not more than five years in prison and a $250,000 fine. The bill also increases the civil penalty for unfair methods of competition (e.g., creating monopolies) and unfair or deceptive acts or practices (e.g., misleading price claims or sale of defective products) during such time period from $10,000 to $50,000 for a first offense and $250,000 for subsequent offenses.

Additionally, the bill makes it unlawful to engage in unfair or deceptive commercial practices that relate to the COVID-19 pandemic during such time period.</summary>
  <committee-reports/>
</bill>
